Loading data
ABATNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 21.74 m USD | 4.29 m USD | 343.5 k USD | — | — |
| Cost of revenue | 24.83 m USD | 14.86 m USD | 3.3 m USD | — | — |
| Gross profit | -3.09 m USD | -10.57 m USD | -2.96 m USD | — | — |
| Research and development expense | 17.87 m USD | 8.47 m USD | 14.33 m USD | 7.57 m USD | 963.39 k USD |
| Operating profit | -74.71 m USD | -42.02 m USD | -47.77 m USD | -22.43 m USD | -33.74 m USD |
| Net income (reported basis) | -73.38 m USD | -46.77 m USD | -52.5 m USD | -22.19 m USD | -33.54 m USD |
| Net income attributable to common shareholders | — | -46.76 m USD | -52.5 m USD | -22.19 m USD | -33.54 m USD |
| Basic earnings per share | -0.58 USD/share | -0.58 USD/share | -1.02 USD/share | -0.51 USD/share | -0.8 USD/share |
| Diluted earnings per share | -0.58 USD/share | -0.58 USD/share | -1.02 USD/share | -0.51 USD/share | -0.8 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.